These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37209450)

  • 41. Artemisinin-derived hybrids and their anticancer activity.
    Gao F; Sun Z; Kong F; Xiao J
    Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
    Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
    Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
    Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
    Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle.
    Raffa D; Maggio B; Raimondi MV; Cascioferro S; Plescia F; Cancemi G; Daidone G
    Eur J Med Chem; 2015 Jun; 97():732-46. PubMed ID: 25549911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Scenario of Acridine Hybrids with Anticancer Potential.
    Zhang Q; Yu X
    Curr Top Med Chem; 2021; 21(19):1773-1786. PubMed ID: 34348622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity.
    Song F; Bian Y; Liu J; Li Z; Zhao L; Fang J; Lai Y; Zhou M
    Curr Top Med Chem; 2021; 21(5):377-403. PubMed ID: 32901583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression.
    Vishnu WK; Abeesh P; Guruvayoorappan C
    Toxicol Appl Pharmacol; 2021 May; 418():115491. PubMed ID: 33737021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The therapeutic voyage of pyrazole and its analogs: A review.
    Khan MF; Alam MM; Verma G; Akhtar W; Akhter M; Shaquiquzzaman M
    Eur J Med Chem; 2016 Sep; 120():170-201. PubMed ID: 27191614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
    Aly HM; El-Gazzar MG
    Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
    Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
    Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in the development of hybrid anticancer drugs.
    Fortin S; Bérubé G
    Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyrazole Containing Anti-HIV Agents: An Update.
    Kumar S; Gupta S; Rani V; Sharma P
    Med Chem; 2022; 18(8):831-846. PubMed ID: 34994333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
    Galal SA; Abdelsamie AS; Shouman SA; Attia YM; Ali HI; Tabll A; El-Shenawy R; El Abd YS; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Girgis AS; El-Diwani HI
    Eur J Med Chem; 2017 Jul; 134():392-405. PubMed ID: 28433679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
    Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
    Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities.
    Fahmy HH; Khalifa NM; Ismail MM; El-Sahrawy HM; Nossier ES
    Molecules; 2016 Feb; 21(3):271. PubMed ID: 26927048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
    Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
    Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current progress on antioxidants incorporating the pyrazole core.
    Silva VLM; Elguero J; Silva AMS
    Eur J Med Chem; 2018 Aug; 156():394-429. PubMed ID: 30015075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.